News tagged with trastuzumab

Adverse prognostic factor ID'd in operable breast cancer

(HealthDay)—For women with operable breast cancer, moderate immunohistochemical expression of human epidermal growth factor receptor (HER)-2 (2+) without amplification of HER-2 (HER-2 2+/HER-2−) is an adverse prognostic ...

Oct 30, 2012
popularity not rated yet | comments 0